Humaid Al-Shamsi: Nexomic Celebrates a Major Milestone with 50 Abstracts at ESMO AI 2026
Humaid Al-Shamsi/LinkedIn

Humaid Al-Shamsi: Nexomic Celebrates a Major Milestone with 50 Abstracts at ESMO AI 2026

Humaid Al-Shamsi, The Chairman of Nexomic, CEO of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared on LinkedIn:

“Dinner in Berlin with our Nexomic family, one team, one vision, one commitment.

Celebrating our massive success at ESMO AI, hitting over 50 Abstracts presented and accepted in 2026.

One word behind this achievement: Believe!

Thank you, ESMO – European Society for Medical Oncology for leading the AI space in oncology.”

You may also be interested in:

Humaid Al-Shamsi: Nexomic Brings the Largest Team Representation to ESMO AI 2026